Clinical trial
Study of the Safety, Tolerability, Immunogenicity, Pharmacokinetics and Pharmacodynamics of the Drug B11-FC With a Single Application in Adults
NCT06580236 is registered in ClinicalTrials.gov with Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study of the Safety, Tolerability, Immunogenicity, Pharmacokinetics and Pharmacodynamics of the Drug B11-FC With a Single Application in Adults
- Lead sponsor
- Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
- Phase
- Phase 1/2
- Overall status
- Unknown status
- Start date
- August 31, 2024
- Completion date
- March 30, 2025
- Enrollment
- 40 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.